HSD17B13 and hepatocellular carcinoma: Furthermore, if this genetic variant truly lowers HSD17B13 enzymatic activity [25,27] and protects the liver, then further investigation is needed to uncover the role of HSD17B13 genetic variants in HCC carcinogenesis and recurrence.